Clinical trials for cellular therapy products: conclusions reached by foreign regulatory bodies

Currently, the problem of adopting viable human cell-based drugs – biomedical cell products (BCPs) – in medical practice in the Russian Federation includes, among others, lack of experience in clinical trials for such drugs and insufficient expert assessment under the national state registration pro...

Full description

Bibliographic Details
Main Authors: E. V. Melnikova, O. V. Merkulova, V. A. Merkulov
Format: Article
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Series:Vestnik Transplantologii i Iskusstvennyh Organov
Online Access: